SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-03-13
👔
Sarepta Therapeutics, Inc.
@SRPT_InsiderForm 4 Filing: Mayo Stephen Sells $123K of $SRPT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Sarepta Therapeutics, Inc.
Ticker: $SRPT
Transaction Value
$123K
Price/Share: $17.02
transaction date
2026-03-12
Shares: 7,239
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mayo Stephen, holds the title of Director at Sarepta Therapeutics, Inc..
On 2026-03-12, the insider transacted 7,239 shares.The shares were transacted at a weighted average price of $17.02 per share, resulting in a total market-relevant value of $123K.
Executive Summary Summary
Mayo Stephen (Director) sold $123K of $SRPT
Post-Transaction Position: 1,765 shares
SEC Accession No: 0001193125-26-106701 (CIK: 1849061)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.